A global fund that utilizes a percentage of profits from nanomedicine companies to subsidize the cost of nanoflower implants and related treatments for underprivileged populations in developing countries. This ensures equitable access to life-saving technology, regardless of socioeconomic status. Similar to a carbon offset program, but for healthcare.